<unk> (nasal) is a serotonin (5-HT1B/1D) receptor agonist that is FDA approved for the treatment of migraine with or without aura in adults.   Common adverse reactions include burning sensation, disorder/discomfort of nasal cavity/sinuses, throat discomfort, nausea and/or vomiting, bad/unusual taste, and dizziness/vertigo.
Sumatriptan 
Eletriptan
Frovatriptan
Rizatriptan
Almotriptan
Naratriptan
Zolmitriptan 
Atogepant